Temple, founded by Deepinder Goyal, has discovered a biomarker called Entropy that measures the body's real-time metabolic cost from the temple region.
Temple, a startup founded by Deepinder Goyal, has announced the discovery of a new biomarker named 'Entropy'. This innovative biomarker is designed to measure the body's real-time metabolic cost. The measurements are specifically taken from the temple region of the body,…
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.